CERVICAL CANCER
Clinical trials for CERVICAL CANCER explained in plain language.
Never miss a new study
Get alerted when new CERVICAL CANCER trials appear
Sign up with your email to follow new studies for CERVICAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Extra chemo tested to keep advanced cervical cancer at bay
Disease control TerminatedThis study tested whether adding extra chemotherapy after standard radiation treatment could help control advanced cervical cancer that had spread to nearby lymph nodes. It involved patients who first completed standard radiation and chemotherapy, then received additional weekly …
Matched conditions: CERVICAL CANCER
Phase: PHASE2 • Sponsor: Centre Oscar Lambret • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Early cancer drug trial halted after initial safety testing
Disease control TerminatedThis early-stage study tested a new drug called INCB099318 in people with advanced solid tumors that had stopped responding to standard treatments. The main goal was to check the drug's safety, how the body processes it, and what side effects it might cause. The trial was termina…
Matched conditions: CERVICAL CANCER
Phase: PHASE1 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Radioactive bullet targets advanced cancers in early trial
Disease control TerminatedThis early-stage study tested a new radioactive drug designed to target and destroy advanced solid tumors. It involved 78 patients with various cancers who had run out of standard treatment options. The main goals were to check the treatment's safety, find the right dose, and see…
Matched conditions: CERVICAL CANCER
Phase: PHASE1 • Sponsor: Fusion Pharmaceuticals Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Early trial tests new combo for Tough-to-Treat cervical cancer
Disease control TerminatedThis early-stage trial tested a combination of two drugs, toripalimab and chidamide, for women with advanced cervical cancer that had returned or spread after standard chemotherapy. The goal was to see if this new drug pair could control the cancer better than existing options an…
Matched conditions: CERVICAL CANCER
Phase: PHASE1, PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New cancer drug trial halted after early testing
Disease control TerminatedThis early-stage study tested a new drug called OC-001, both by itself and combined with an existing immunotherapy drug, in people with various advanced cancers that had stopped responding to standard treatments. The main goal was to check the safety of the drug and see how the b…
Matched conditions: CERVICAL CANCER
Phase: PHASE1, PHASE2 • Sponsor: Ocellaris Pharma, Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
New cancer drug enters human testing for advanced tumors
Disease control TerminatedThis first-in-human study tested a new cancer drug called PHN-010 in patients with advanced solid tumors that had stopped responding to standard treatments. The main goals were to check the drug's safety, determine the right dose, and see if it could shrink tumors. The trial incl…
Matched conditions: CERVICAL CANCER
Phase: PHASE1 • Sponsor: Pheon Therapeutics • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
Could a helping hand stop cervical cancer?
Disease control TerminatedThis study tested whether connecting low-income women with help for basic needs like food, housing, and transportation would help them attend a crucial follow-up appointment after an abnormal cervical cancer screening. It was a small trial that ended early. The goal was to see if…
Matched conditions: CERVICAL CANCER
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Mar 02, 2026 15:26 UTC
-
Study tests gentler tool for uncomfortable cervical procedure
Diagnosis TerminatedThis study aimed to compare two tools used to collect cells from inside the cervix during a diagnostic procedure. It tested whether a brush-like tool (cytobrush) causes less pain than the standard scraping tool (Kevorkian curette) while still collecting enough cells for accurate …
Matched conditions: CERVICAL CANCER
Phase: NA • Sponsor: University Hospital, Lille • Aim: Diagnosis
Last updated Mar 24, 2026 12:03 UTC
-
Blood test research aims to spot cervical cancer spread earlier
Knowledge-focused TerminatedThis study aimed to see if tracking tiny pieces of cancer-related DNA from the HPV virus in the blood could help monitor cervical cancer and detect its spread sooner. Researchers enrolled 26 patients with cervical cancer to test new lab methods for finding this DNA. The goal was …
Matched conditions: CERVICAL CANCER
Phase: NA • Sponsor: Institut Curie • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:17 UTC